The corporate cancer of social justice convergence is costing corporations literal billions of dollars even as it drives both productive employees and loyal customers away, destroys valuable brands, and eats away at market capitalizations. CORPORATE CANCER is a must-read for corporate employees, managers, and executives alike.
Hiding Politics in Plain Sight examines the costs of market mechanisms, especially cause marketing, as a strategy for change. Industry and corporate-connected individuals use market mechanisms to brand issues like breast cancer widely, shaping public understanding. But framed as consensus-based social issues rather than contentious political issues, they essentially hide politics in plain sight.
From the National Book Award finalist and author of "When Smoke Ran Like Water" comes this searing, haunting, and deeply personal account of how a major public health effort was diverted and distorted for private gain.
Developed by the American Cancer Society this new textbook designed for a wide range of learners and practitioners is a comprehensive reference covering the diagnosis of cancer, and a range of related issues that are key to a multidisciplinary approach to cancer and critical to cancer control and may be used in conjunction with the book, The American Cancer Society's Oncology in Practice: Clinical Management. Edited by leading clinicians in the field and a stellar contributor list from the US and Europe, this book is written in an easy to understand style by multidisciplinary teams of medical oncologists, radiation oncologists and other specialists, reflecting day-to-day decision-making and clinical practice. Input from pathologists, surgeons, radiologists, and other specialists is included wherever relevant and comprehensive treatment guidelines are provided by expert contributors where there is no standard recognized treatment. This book is an ideal resource for anyone seeking a deeper understanding of cancer prevention, screening, and follow-up, which are central to the ACS's worldwide mission on cancer control.
This is a guidebook for personal and corporate self-assessment. It was written with a market research approach in mind where many hard questions are asked amidst the different conditions that may have caused or is causing a company to be in distress with an imminent possibility of total bankruptcy. This is a book that supports the author’s advocacy of creating jobs by creating great companies.
Developed by the American Cancer Society this new textbook designed for a wide range of learners and practitioners comprehensively addresses all aspects of clinical management for cancer taking a balanced, authoritative and, -where possible- evidence-based stance and may be used in conjunction with the book, The American Cancer Society's Principles of Oncology: Prevention to Survivorship. Edited by leading clinicians in the field and a stellar contributor list from the US and Europe, this book is written in an easy to understand style by multidisciplinary teams of medical oncologists, radiation oncologists and other specialists, reflecting day-to-day decision-making and clinical practice. Input from pathologists, surgeons, radiologists, and other specialists is included wherever relevant and comprehensive treatment guidelines are provided by expert contributors where there is no standard recognized treatment. This book is an ideal resource for anyone seeking a practical understanding of the field of oncology.
A noted social critic and the author of "When Corporations Rule the World" offers a practical, human-centered alternative to global capitalism run amok.
"Comprehensive...a valuable [addition] to the library of any head and neck surgeon. Of similar value to neurosurgeons dealing specifically with the skull base." --Journal of Neurosurgery. The latest edition of this definitive reference delivers state-of-the-art coverage of every aspect of head and neck cancer. Authors are all experts in their fields, with two new editors bringing fresh up-to-date perspectives. The 4th Edition takes a multidisciplinary approach to surgery and management, bringing new information on topics such as reconstruction of the vocal chords, treatment of laryngeal cancer, and radiotherapy. Features cutting-edge coverage of radiologic evaluation, including the diagnosis and progression of cancers via PET scanning. Includes new information on the treatment of cancer of the nasopharanx, plus the surgical treatment of recurrent nasopharangeal cancer. Discusses the use of combined chemotherapy and radiation to preserve the larynx in patients with advanced cancer in this area. Presents the very latest developments in the management of unusual tumors such as hemangiomas and arteriovenous malformation of the head and neck Describes five new areas of reconstruction of major defects in the head and neck following surgery: anterolateral thigh flap, palatomaxillary reconstruction, reconstruction of the cheek, posterior scalping flap, and submental island flap. Discusses the current status of immunotherapy in treating head and neck cancer.
Lee Johnson was a man with simple dreams. All he wanted was a steady job and a nice home for his wife and children, something better than the hard life he knew growing up. He never imagined that he would become the face of a David-and-Goliath showdown against one of the world’s most powerful corporate giants. But a workplace accident left Lee doused in a toxic chemical and facing a deadly cancer that turned his life upside down. In 2018, the world watched as Lee was thrust to the forefront of one the most dramatic legal battles in recent history. The Monsanto Papers is the inside story of Lee Johnson’s landmark lawsuit against Monsanto. For Lee, the case was a race against the clock, with doctors predicting he wouldn’t survive long enough to take the witness stand. For the eclectic band of young, ambitious lawyers representing him, it was a matter of professional pride and personal risk, with millions of dollars and hard-earned reputations on the line. For the public at large, the lawsuit presented a question of corporate accountability. With enough money and influence, could a company endanger its customers, hide evidence, manipulate regulators, and get away with it all—for decades? Readers will be astounded by the depth of corruption uncovered, captivated by the shocking twists, and moved by Lee’s quiet determination to see justice served. With gripping narrative force that reads like fiction, The Monsanto Papers takes readers behind the scenes of a grueling legal battle, pulling back the curtain on the frailties of the American court system and the lengths to which lawyers will go to fight corporate wrongdoing.